| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 11/25/2010 | US20100298332 Substituted Spirocyclic Piperidine Derivatives as Histamine-3 (H3) Receptor Ligands |
| 11/25/2010 | US20100298330 Haloallylamine inhibitors of ssao/vap-1 and uses therefor |
| 11/25/2010 | US20100298325 Pyridine derivatives for the treatment of amyloid-related diseases |
| 11/25/2010 | US20100298322 Quinazolines and Related Heterocyclic Compounds, and Their Therapeutic Use |
| 11/25/2010 | US20100298319 Pyrimidine substituted purine derivatives |
| 11/25/2010 | US20100298314 Novel jnk inhibitors |
| 11/25/2010 | US20100298312 Substituted pyrimidinyl-amines as protein kinase inhibitors |
| 11/25/2010 | US20100298311 Tetrahydronaphthalene derivates, process for preparing them and their use as antiinflammatory agents |
| 11/25/2010 | US20100298309 Tricyclic triazolic compounds |
| 11/25/2010 | US20100298306 (1,4-Diaza-bicyclo[3.2.2]non-6-en-4-yl)-heterocyclyl-methanone Ligands for Nicotinic Acetylcholine Receptors, Useful for the Treatment of Disease |
| 11/25/2010 | US20100298302 Novel protein kinase modulators |
| 11/25/2010 | US20100298300 Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases |
| 11/25/2010 | US20100298299 non-peptide derivatives as bradykinin b1 antagonists |
| 11/25/2010 | US20100298296 Oligomer-Tricyclic Conjugates |
| 11/25/2010 | US20100298286 Organic Compounds |
| 11/25/2010 | US20100298285 Biclycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof |
| 11/25/2010 | US20100298269 Prodrugs of cgrp receptor antagonists |
| 11/25/2010 | US20100298258 Analgesic compositions |
| 11/25/2010 | US20100298236 Soluble gp130 muteins with improved binding activity |
| 11/25/2010 | US20100298232 Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof |
| 11/25/2010 | US20100298227 Treatment of autoimmune conditions with Copolymer 1 and related copolymers |
| 11/25/2010 | US20100298225 Peptide gap junction modulators |
| 11/25/2010 | US20100298217 Csf-1r mutants |
| 11/25/2010 | US20100298208 Biofilm prevention using lactoferrin |
| 11/25/2010 | US20100297269 Compositions for intranasal administration |
| 11/25/2010 | US20100297255 Malleable implants containing demineralized bone matrix |
| 11/25/2010 | US20100297252 Nanoparticulate meloxicam formulations |
| 11/25/2010 | US20100297229 Tapentadol compositions |
| 11/25/2010 | US20100297224 NSAID Dose Unit Formulations with H2-Receptor Antagonists and Methods of Use |
| 11/25/2010 | US20100297222 Method for production of microcapsules using solid fat |
| 11/25/2010 | US20100297151 Antibodies against human il-21 receptor and uses therefor |
| 11/25/2010 | US20100297150 Disease treatment via antimicrobial peptide inhibitors |
| 11/25/2010 | US20100297149 Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities |
| 11/25/2010 | US20100297139 Methods and compositions for the treatment of proteinuric diseases |
| 11/25/2010 | US20100297135 Epitope for neutralizing antibodies |
| 11/25/2010 | US20100297125 Methods of treating pain using antagonists of il-31, il-31ra and/or osmrb |
| 11/25/2010 | US20100297111 Nanobodies against tumor necrosis factor-alpha |
| 11/25/2010 | US20100297106 Pharmaceutical Formulations |
| 11/25/2010 | US20100297099 Airway Administration of Activated Protein C in Inflammatory Conditions Affecting the Respiratory Tract |
| 11/25/2010 | US20100297094 Therapy or prevention of diseases with cells or cell supernatant |
| 11/25/2010 | US20100297077 Novel aryl potassium channel blockers and uses thereof |
| 11/25/2010 | US20100297069 Pegylated interleukin-10 |
| 11/25/2010 | US20100297066 Biodegradable peptide releasing polymers |
| 11/25/2010 | US20100297058 Prebiotic composition |
| 11/25/2010 | US20100297046 Compositions and Methods Related to Fructosamine-3-Kinase Inhibitors |
| 11/25/2010 | US20100297037 Material composition for oral hygiene product |
| 11/25/2010 | US20100297031 Orodispersible tablets |
| 11/25/2010 | US20100297025 Novel compositions magnetic particles covered with gem-bisphosphonate derivatives |
| 11/25/2010 | CA2762939A1 Self-emulsifying composition of .omega.3 fatty acid |
| 11/25/2010 | CA2762805A1 1,4-dihydropyridine derivatives and their uses |
| 11/25/2010 | CA2762665A1 Prebiotic composition |
| 11/25/2010 | CA2762226A1 Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors |
| 11/25/2010 | CA2762212A1 Elastin for soft tissue augmentation |
| 11/25/2010 | CA2761954A1 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors |
| 11/25/2010 | CA2761254A1 Anti-inflammatory composition containing macrolactin a and a derivative thereof as active ingredients |
| 11/25/2010 | CA2753560A1 Inhibitors of phosphatidylinositol 3-kinase |
| 11/24/2010 | EP2253646A1 Anti-dual integrin antibody and compositions and conjugates comprising said antibody |
| 11/24/2010 | EP2253642A1 Polypeptides, cDNAs encoding the same and utilization thereof |
| 11/24/2010 | EP2253314A2 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 11/24/2010 | EP2252633A1 Anti-trka antibodies and derivatives thereof |
| 11/24/2010 | EP2252615A1 Dihydro- 1h- pyrrolo [1,2-a]indol-1-yl carboxylic derivatives which act as s1p1 agonists |
| 11/24/2010 | EP2252612A1 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 11/24/2010 | EP2252608A1 Method for treating pain syndrome and other disorders |
| 11/24/2010 | EP2252583A1 3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activity |
| 11/24/2010 | EP2252327A2 Methods of treating copd |
| 11/24/2010 | EP2252324A1 Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases |
| 11/24/2010 | EP2252318A2 Methods of treating inflammation |
| 11/24/2010 | EP2252294A1 Use of ranolazine for treating pain |
| 11/24/2010 | EP2252280A1 Use of eicosapentaenoic acid and/or docosahexahenoic acid in women with endometriosis |
| 11/24/2010 | EP2252278A2 Compounds for use in the treatment of neuropathic pain |
| 11/24/2010 | EP1901734B1 Compositions comprising crystalline trans-(+/-)-delta-9-tetrahydrocannabinol |
| 11/24/2010 | EP1899330B1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect |
| 11/24/2010 | EP1546375B1 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 11/24/2010 | EP1539739B1 Piperidinyl compounds that selectively bind integrins |
| 11/24/2010 | EP1497285B1 Benzoxazinone-derived compounds, their preparation und use as medicaments |
| 11/24/2010 | EP1326896B1 Human anti-cd40 antibodies |
| 11/24/2010 | EP1276486B1 Joint repair using mesenchymal stem cells |
| 11/24/2010 | CN201642568U Meridian therapeutic band for internal medicine in hospital |
| 11/24/2010 | CN201640466U Health-care underpants |
| 11/24/2010 | CN201640463U Healthcare underwear |
| 11/24/2010 | CN101896179A Tape preparation comprising etodolac in ionic liquid form |
| 11/24/2010 | CN101892252A Gene for encoding muramidase and application of same |
| 11/24/2010 | CN101892249A Pufa polyketide synthase systems and uses thereof |
| 11/24/2010 | CN101892236A Construction and application of RNA interference expression vector of targeted ZNF268 gene |
| 11/24/2010 | CN101891817A Monoclonal antibody capable of preventing high mobility group box-1 (HMGB-1) and application thereof |
| 11/24/2010 | CN101891775A 6-hydroxy-2-O-beta-D-glucopyranose base heptane, and preparation method and application thereof |
| 11/24/2010 | CN101891738A Dasatinib polymorph and preparation method and medical composite thereof |
| 11/24/2010 | CN101891730A Synthesizing method of 7-alkoxy methyl hesperetin and pharmaceutical use thereof |
| 11/24/2010 | CN101891726A Iguratimod crystalline form and composite thereof |
| 11/24/2010 | CN101890163A Use of anti-tnfalpha antibodies and another drug |
| 11/24/2010 | CN101890154A Application of cobra short-chain neurotoxin in preparation of immunosuppressive drugs |
| 11/24/2010 | CN101890150A Novel and special Likexiao |
| 11/24/2010 | CN101890121A External medicinal composition for treating acute soft tissue injury and preparation method and application thereof |
| 11/24/2010 | CN101890114A Li nation medicament extract and composition with bacteriostatic, anti-inflammatory and hemostasis effects and preparation method thereof |
| 11/24/2010 | CN101890104A Chinese medicament for treating neck, shoulder, waist and leg pains |
| 11/24/2010 | CN101890103A External thermal therapy bag for treating aches and pains in human necks, shoulders, waists and legs |
| 11/24/2010 | CN101890099A Quick pain-relieving cathartic wine |
| 11/24/2010 | CN101890089A Formula for treating periarthritis of shoulder and preparation method thereof |
| 11/24/2010 | CN101890087A Composition containing coptis root, rhubarb and baikal skullcap root |
| 11/24/2010 | CN101890084A Semen nigellae total glycoside extract and preparation method and application thereof |